AURA · Aura Biosciences, Inc. · Documents
Market Cap
$725.93M
Shares
103.70M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-11 | — | |
| 10-Q | 2026-08-11 | 2026-06-30 | |
| 8-K | 2026-08-05 | — | |
| 8-K | 2026-07-08 | 2026-07-03 | |
| DEF 14A | 2026-06-29 | 2026-08-05 | |
| 8-K | 2026-06-11 | — | |
| 8-K | 2026-05-11 | — | |
| 10-Q | 2026-05-11 | 2026-03-31 | |
| 8-K | 2026-05-05 | 2026-05-04 | |
| 8-K | 2026-05-04 | 2026-04-30 | |
| 8-K | 2026-05-04 | 2026-04-29 | |
| DEF 14A | 2026-04-20 | 2026-06-11 | |
| 10-K | 2026-03-30 | 2025-12-31 | |
| 8-K | 2026-03-30 | — | |
| 8-K | 2025-11-13 | — | |
| 10-Q | 2025-11-13 | 2025-09-30 | |
| 10-Q | 2025-08-13 | 2025-06-30 | |
| 8-K | 2025-08-13 | — | |
| 8-K | 2025-06-18 | 2025-06-17 | |
| 8-K | 2025-05-16 | 2025-05-15 | |
| 8-K | 2025-05-15 | 2025-05-13 | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| DEF 14A | 2025-04-24 | 2025-06-17 | |
| 8-K | 2025-04-02 | 2025-03-31 | |
| 8-K | 2025-03-24 | — | |
| 10-K | 2025-03-24 | 2024-12-31 | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-11-12 | — | |
| 8-K | 2024-10-17 | — | |
| 8-K | 2024-09-27 | 2024-09-23 | |
| 8-K | 2024-09-12 | — | |
| 8-K | 2024-08-08 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-06-21 | 2024-06-20 | |
| 10-K/A | 2024-06-14 | 2023-12-31 | |
| 8-K | 2024-06-04 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-09 | — | |
| DEF 14A | 2024-04-25 | 2024-06-20 | |
| 8-K | 2024-04-15 | 2024-04-12 | |
| 8-K | 2024-03-27 | — | |
| 10-K | 2024-03-27 | 2023-12-31 | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2023-11-09 | — | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 8-K | 2023-11-06 | — | |
| 8-K | 2023-10-02 | 2023-09-26 | |
| 10-Q | 2023-08-09 | 2023-06-30 | |
| 8-K | 2023-08-09 | — | |
| 8-K | 2023-06-07 | — |
Showing 1–50 of 79 filings